Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02435979 · ClinicalTrials.gov registry record · NA
Proximal Strengthening for the Management of Wrist Pain
A NA study of Wrist Injuries, sponsored by Mitchell Selhorst.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 4
- Study locations
NCT02435979: Completed NA study of Wrist Injuries, sponsored by Mitchell Selhorst.
NCT02435979 is a NA study of Wrist Injuries that has completed, run by Mitchell Selhorst. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02435979, a NA study of Wrist Injuries, has completed, sponsored by Mitchell Selhorst.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will be a randomized controlled trial comparing proximal strengthening vs. traditional hand therapy for patients with wrist pain. Patients will attend 2 hand therapy sessions per week for 4 weeks. Change in patient function and pain as measured by the patient rated wrist evaluation will be the primary outcome of interest
Primary Outcome
The PRWE is a 15 item self-report questionnaire which measure pain and function. It has been found valid and reliable for measure changes in pain and function for patients with wrist pain. The minimal clinical important difference of this scale is 14 (Sorensen, 2013).
Conditions Studied
Interventions
- OTHER hand therapy
- OTHER Proximal Strengthening
Study Locations (4)
Ohio
- Nationwide Children's Hospital Sports and Ortho PT Ortho Center - Columbus
- Nationwide Children's Hospital Sports and Ortho PT East Broad - Columbus
- Nationwide Children's Hospital Sports and Ortho PT Dublin - Dublin
- Nationwide Children's Hospital Sports and Ortho PT Westerville - Westerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-07 |
| Phase | NA |
What the finished NCT02435979 record still lists
NCT02435979 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Wrist Injuries appearing as the primary indexed condition, and to 2 interventions - of which hand therapy is the first listed.
NCT02435979 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02435979 about?
NCT02435979 is a clinical study titled "Proximal Strengthening for the Management of Wrist Pain". This study will be a randomized controlled trial comparing proximal strengthening vs. traditional hand therapy for patients with wrist pain. Patients will attend 2 hand therapy sessions per week for 4 weeks. Change in patient function and pain as measured by the patient rated wrist evaluation will b...
What is the current status of trial NCT02435979?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2015-05. Estimated completion is 2019-07.
What conditions does trial NCT02435979 study?
This clinical trial studies the following conditions: Wrist Injuries.
What interventions are being tested in trial NCT02435979?
The interventions under investigation include: hand therapy (OTHER), Proximal Strengthening (OTHER).
Who is sponsoring clinical trial NCT02435979?
This trial is sponsored by Mitchell Selhorst, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02435979 being conducted?
This trial has 4 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02435979's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia